Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of...
Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of 5% convertible senior notes due 2017. The company plans to use the proceeds to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes.
From other sites
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs